Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (491-500 of 659) with videos related to

Pageof 66
Sort By:
Journal of Medicinal Chemistry|February 7, 2003
Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amidesGeorge R Pettit, Collin R Anderson, Delbert L Herald, et al.
Journal of Natural Products|March 15, 2012
Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice FolliesGeorge R Pettit, Rui Tan, Guan-Hu Bao, et al.
Arthritis Research & Therapy|November 23, 2012
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitorsKatelin R Haynes, Allison R Pettit, Ran Duan, et al.
Journal of Natural Products|May 27, 2006
Antineoplastic Agents. 554. The manitoba bacterium Streptomyces spGeorge R Pettit, Jiang Du, Robin K Pettit, et al.
Journal of Natural Products|July 1, 1980
The antineoplastic quassinoids of Simaba cuspidata spruce and Ailanthus grandis PrainJ Polonsky, Z Varon, C Moretti, et al.
Cancer Research|May 1, 1996
The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1Z Szallasi, L Du, R Levine, et al.
Anticancer Research|January 30, 2003
Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphateS E Holwell, P A Cooper, M J Thompson, et al.
Anti-Cancer Drug Design|June 1, 1995
Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugsG R Pettit, C Temple, V L Narayanan, et al.
Rheumatology (Oxford, England)|November 16, 2001
Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritisA R Pettit, H Weedon, M Ahern, et al.
Nephron|May 22, 2002
Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysisG Hampson, S Vaja, C Evans, et al.
Pageof 66

Showing results (491-500 of 659) with videos related to

Sort By:
Pageof 66
Journal of Medicinal Chemistry|February 7, 2003
Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amidesGeorge R Pettit, Collin R Anderson, Delbert L Herald, et al.
Journal of Natural Products|March 15, 2012
Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice FolliesGeorge R Pettit, Rui Tan, Guan-Hu Bao, et al.
Arthritis Research & Therapy|November 23, 2012
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitorsKatelin R Haynes, Allison R Pettit, Ran Duan, et al.
Journal of Natural Products|May 27, 2006
Antineoplastic Agents. 554. The manitoba bacterium Streptomyces spGeorge R Pettit, Jiang Du, Robin K Pettit, et al.
Journal of Natural Products|July 1, 1980
The antineoplastic quassinoids of Simaba cuspidata spruce and Ailanthus grandis PrainJ Polonsky, Z Varon, C Moretti, et al.
Cancer Research|May 1, 1996
The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1Z Szallasi, L Du, R Levine, et al.
Anticancer Research|January 30, 2003
Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphateS E Holwell, P A Cooper, M J Thompson, et al.
Anti-Cancer Drug Design|June 1, 1995
Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugsG R Pettit, C Temple, V L Narayanan, et al.
Rheumatology (Oxford, England)|November 16, 2001
Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritisA R Pettit, H Weedon, M Ahern, et al.
Nephron|May 22, 2002
Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysisG Hampson, S Vaja, C Evans, et al.
Pageof 66